Mechanisms of hepatic toxicity: I. TNF-induced liver injury

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 275, Issue 3 38-3, 1998, Pages

  Bradham, Cynthia A ^a   Plümpe, Jörg ^b   Manns, Michael P ^b   Brenner, David A ^a   Trautwein, Christian ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Alcoholic liver disease; Concanavalin A; Fulminant hepatic failure; Lipopolysaccharide; Liver regeneration; Tumor necrosis factor receptor; Viral hepatitis

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CONCANAVALIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ALCOHOL LIVER DISEASE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DRUG CYTOTOXICITY; HUMAN; LIVER FAILURE; LIVER INJURY; LIVER REGENERATION; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 0031682110     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1998.275.3.g387     Document Type: Article

References (35)

1. Akerman, P., P. Cote, S. Q. Yang, C. McClain, S. Nelson, G. J. Bagby, and A. M. Diehl. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263 (Gastrointest. Liver Physiol. 26): G579-G585, 1992.
2. Bird, G. L.A., N. Sheron, J. Goka, G. J. Alexander, and R. S. Williams. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann. Intern. Med. 112: 917-920, 1990.
3. Bohlinger, I., M. Leist, J. Barsig, S. Uhlig, G. Tiegs, and A. Wendel. Interleukin-1 and nitric oxide protect against tumor necrosis factor α-induced liver injury through distinct pathways. Hepatology 22: 1829-1837, 1995.
4. Boldin, M. P., T. M. Goncharov, Y. V. Golstev, and D. Wallach. Involvement of MACH, a novel MORT1/FADD-interacting protease in Fas/APO-1 and TNF receptor induced cell death. Cell 81: 803-815, 1996.
5. Daniels, H., A. Meager, J. Goka, A. L. W. F. Eddlestone, G. J. M. Alexander, and R. Williams. Spontaneous production of tumour necrosis factor α and interleukin β during interferon treatment of chronic HBV infection. Lancet 335: 875-877, 1990.
6. Diehl, A. M., M. Yin, J. Fleckenstein, S. Q. Yang, H. Z. Lin, D. A. Brenner, J. Westwick, G. Bagby, and S. Nelson. Tumor necrosis factor-α induces c-jun during the regenerative response to liver injury. Am. J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G552-G561, 1994.
7. Gantner, F., M. Leist, A. W. Lohse, P. G. Germann, and A. Tiegs. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190-198, 1995.
8. Gonzalez-Amaro, R., C. Garcia-Monzon, L. Garcia-Buey, R. Moreno-Otero, J. L. Lonso, E. Yague, J. P. Pivel, M. Lopez-Cabrera, E. Fernandez-Ruiz, and F. Sanchez-Madrid. Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179: 841-848, 1994.
9. Grove, J., A. K. Daly, M. F. Bassendine, and C. Day. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steotohepatitis. Hepatology 26: 143-146, 1997.
10. Hsu, H., H. B. Shu, M. G. Pan, and D. V. Goeddel. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308, 1996.
11. Iimuro, Y., R. M. Gallucci, M. I. Luster, H. Kono, and R. G. Thurman. Antibodies to tumor necrosis factor α attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26: 1530-1537, 1997.
12. Iimuro, Y., T. Nishiura, C. Hellerbrand, K. Behrns, R. Schoonhoven, J. W. Grisham, and D. A. Brenner. NF-κB prevents apoptosis and liver failure during liver regeneration. J. Clin. Invest. 101: 802-811, 1998.
13. Israel, A. IκB kinase all zipped up. Nature 388: 519-521, 1997.
14. Jaeschke, H., M. A. Fisher, J. A. Lawson, C. A. Simmons, A. Farhood, and D. A. Jones. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-α-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine shock model. J. Immunol. 160: 3480-3486, 1998.
15. Küsters, S., G. Tiegs, L. Alexopoulou, M. Pasarakis, E. Douni, G. Künstle, H. Blüthmann, A. Wendel, K. Pfizenmaier, G. Kollias, and M. Grell. In vivo evidence for a functional role of both tumor necrosis (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 27: 2870-2875, 1997.
16. Larrea, E., N. Garcia, C. Qian, M. P. Civeira, and J. Prieto. Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C. Hepatology 23: 210-217, 1996.
17. Leist, M., F. Gantner, S. Jilg, and A. Wendel. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154: 1307-1316, 1995.
18. Lenczowski, J. M., L. Dominguez, A. E. Eder, L. B. King, C. M. Zacharchuk, and J. D. Ashwell. Lack of a role for jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol. 17: 170-181, 1997.
19. Liu, Z. G., H. Hsu, D. V. Goedell, and M. Karin. Dissection of TNF receptor 1 effector functions. JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87: 565-576, 1996.
20. Loffreda, S., R. Rai, S. Q. Yang, H. Z. Lin, and A. M. Diehl. Bile ducts and portal and central veins are major producers of tumor necrosis factor α in regenerating rat liver. Gastroenterology 112: 2089-2098, 1997.
21. McClain, C. J. Tumor necrosis factor and alcoholic hepatitis. Hepatology 14: 394-396, 1991.
22. Mizuhara, H., E. O'Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara. T-cell activation-associated hepatic-injury: mediation by tumor necrosis factor and protection by interleukin 6. J. Exp. Med. 179: 1529-1537, 1994.
23. Muto, Y., K. T. Nouri-Aria, A. Meager, G. J. Alexander, A. L. Eddleston, and R. Williams. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 8602: 72-74, 1998.
24. Natoli, G., A. Costanzo, A. Ianni, D. J. Templeton, J. R. Woodgett, C. Balsano, and M. Levrero. Activation of SAPK/ JNK by a noncytotoxic TRAF2-dependent pathway. Science 275: 200-203, 1997.
25. Pan, G., K. O'Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113, 1997.
26. Pfeffer, K., T. Matsuyama, T. M. Kündig, A. Wakeha, K. Kishiara, A. Shahinian, K. Wiegmann, P. S. Ohashl, M. Krönke, and T. W. Mak. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467, 1993.
27. Ray, R. B., K. Meyer, R. Steele, A. Shrivastava, B. B. Aggarwal, and R. Ray. Inhibition of tumor necrosis factor (TNF-α)-mediated apoptosis by hepatitis C virus core protein. J. Biol. Chem. 273: 2256-2259, 1998.
28. Tagawa, Y. I., K. Sekikawa, and Y. Iwakura. Suppression of concanavalin A-induced hepatitis in IFN-γ -/- mice, but not in TNFα -/- mice. J. Immunol. 159: 1418-1428, 1997.
29. Tiegs, G., J. Hentschel, and A. Wendel. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90: 196-203, 1992.
30. Trautwein, C., T. Rakemann, D. A. Brenner, K. Streetz, L. Licato, M. P. Manns, and G. Tiegs. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor. Gastroenterology 114: 1035-1045, 1998.
31. Trautwein, C., T. Rakemann, N. P. Malek, J. Plümpe, G. Tiegs, and M. P. Manns. Concanavalin A-induced liver injury triggers hepatocyte proliferation. J. Clin. Invest. 101: 1960-1969, 1998.
32. Van Zee, T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factors α in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89: 4848-4849, 1992.
33. Wang, C. Y., M. W. Mayo, and A. S. Baldwin. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274: 784-787, 1996.
34. Yamada, Y., I. Kirillova, J. J. Peschon, and N. Fausto. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 94: 1441-1446, 1997.
35. Yeh, W. C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J. L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, P. Ohashi, M. Rothe, D. V. Goeddel, and T. M. Mak. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725, 1997.